Related Experiment Video
Updated: Dec 18, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.6K
Stratifying patients using fast multiple kernel learning framework: case studies of Alzheimer's disease and cancers
Thanh-Trung Giang1,2, Thanh-Phuong Nguyen3,4, Dang-Hung Tran5
1VNU University of Engineering and Technology, Hanoi, Vietnam.
BMC Medical Informatics and Decision Making
|June 18, 2020
Summary
This study introduces fMKL-DR, a novel framework for fast multiple kernel learning, improving patient stratification accuracy and efficiency for Alzheimer's disease and various cancers. The method enhances data integration and dimension reduction for personalized medicine.
Area of Science:
- Biomedical data analysis
- Machine learning in healthcare
- Computational biology
Background:
- Predictive patient stratification is crucial for personalized medicine, identifying patients who will benefit from specific interventions.
- Integrating heterogeneous and high-dimensional biomedical data presents significant computational and machine learning challenges.
- Existing methods struggle with vast dimensional space handling and data type disparities in machine learning for biomedical data.
Purpose of the Study:
- To develop an efficient machine learning framework for handling complex biomedical data integration and stratification.
- To propose a fast multiple kernel learning framework (fMKL-DR) for optimizing matrix chain multiplication and data dimension reduction.
- To validate the fMKL-DR framework in real-world case studies for Alzheimer's disease and cancer patient stratification.
Main Methods:
- Developed a fast multiple kernel learning framework (fMKL-DR) optimizing matrix chain multiplication for dimension reduction.
- Applied the fMKL-DR framework to Alzheimer's disease (AD) patient stratification using MRI data.
- Utilized the fMKL-DR framework for stratifying six types of cancer by integrating gene expression, miRNA expression, and DNA methylation data.
Main Results:
- Achieved high accuracy (AUC close to 1) in classifying AD patients and different disease phases using MRI data.
- Demonstrated significantly improved classification accuracy for cancer patients by integrating multiple data types compared to single data types.
- The fMKL-DR framework successfully integrated gene expression, miRNA expression, and DNA methylation for cancer stratification.
Conclusions:
- The fMKL-DR framework significantly reduces computational cost and enhances accuracy in AD and cancer patient stratification.
- Optimized data integration, dimension reduction, and kernel fusion processes within the framework.
- fMKL-DR shows great potential for analyzing large-scale cohort data and advancing personalized prevention strategies.
Related Concept Videos
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment
668
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
668

